3/30
09:55 am
teva
Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab) [Yahoo! Finance]
Low
Report
Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab) [Yahoo! Finance]
3/30
08:00 am
teva
Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)
Low
Report
Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)
3/30
05:45 am
teva
Assessing Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After A Sharp One Month Share Price Pullback [Yahoo! Finance]
Low
Report
Assessing Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After A Sharp One Month Share Price Pullback [Yahoo! Finance]
3/19
04:45 pm
teva
Teva to Host Conference Call to Discuss First Quarter 2026 Financial Results at 8 a.m. ET on April 29, 2026 [Yahoo! Finance]
Low
Report
Teva to Host Conference Call to Discuss First Quarter 2026 Financial Results at 8 a.m. ET on April 29, 2026 [Yahoo! Finance]
3/19
04:30 pm
teva
Teva to Host Conference Call to Discuss First Quarter 2026 Financial Results at 8 a.m. ET on April 29, 2026
Medium
Report
Teva to Host Conference Call to Discuss First Quarter 2026 Financial Results at 8 a.m. ET on April 29, 2026
3/19
04:30 pm
teva
Teva Releases Q1 2026 Aide Memoire
Medium
Report
Teva Releases Q1 2026 Aide Memoire
3/17
07:12 am
teva
Yahoo Finance [Yahoo! Finance]
Low
Report
Yahoo Finance [Yahoo! Finance]
3/15
08:05 pm
teva
Is It Too Late To Reassess Teva Pharmaceutical Industries (TEVA) After Its 75% One Year Rally? [Yahoo! Finance]
Medium
Report
Is It Too Late To Reassess Teva Pharmaceutical Industries (TEVA) After Its 75% One Year Rally? [Yahoo! Finance]
3/15
05:38 pm
teva
Is Teva Pharmaceutical Industries (TEVA) A Good Stock To Buy Now? [Yahoo! Finance]
Medium
Report
Is Teva Pharmaceutical Industries (TEVA) A Good Stock To Buy Now? [Yahoo! Finance]
3/15
07:30 am
teva
Does Blackstone's Private Credit Strains And AI Push With Anthropic Reshape The Bull Case For BX? [Yahoo! Finance]
Medium
Report
Does Blackstone's Private Credit Strains And AI Push With Anthropic Reshape The Bull Case For BX? [Yahoo! Finance]
3/15
05:25 am
teva
A Look At Teva Pharmaceutical Industries (TEVA) Valuation After Recent Share Price Pullback [Yahoo! Finance]
Medium
Report
A Look At Teva Pharmaceutical Industries (TEVA) Valuation After Recent Share Price Pullback [Yahoo! Finance]
3/10
10:32 am
teva
Teva Pharmaceutical Industries Limited (TEVA) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
Low
Report
Teva Pharmaceutical Industries Limited (TEVA) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
3/10
10:12 am
teva
Skyhawk Therapeutics Appoints Aaron Deves as Chief Commercial Officer to Lead Commercialization of SKY-0515 for Huntington's Disease [Yahoo! Finance]
Low
Report
Skyhawk Therapeutics Appoints Aaron Deves as Chief Commercial Officer to Lead Commercialization of SKY-0515 for Huntington's Disease [Yahoo! Finance]
3/9
04:35 pm
teva
Teva Pharmaceutical Industries Limited (TEVA) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]
Low
Report
Teva Pharmaceutical Industries Limited (TEVA) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]
3/5
02:28 pm
teva
Billionaire Stanley Druckenmiller Dumped 2 of His Top Performers -- Teva and Taiwan Semiconductor -- and Made This Sector-Based ETF His Fund's New No. 2 Holding [Yahoo! Finance]
Low
Report
Billionaire Stanley Druckenmiller Dumped 2 of His Top Performers -- Teva and Taiwan Semiconductor -- and Made This Sector-Based ETF His Fund's New No. 2 Holding [Yahoo! Finance]
3/4
02:23 pm
teva
Forget Teva: This Dividend Top Dog Is the Real Value Buy Today [Yahoo! Finance]
Low
Report
Forget Teva: This Dividend Top Dog Is the Real Value Buy Today [Yahoo! Finance]
3/4
12:18 pm
teva
Medincell to Participate in Leerink and Jefferies Miami Investor Conferences, March 8 – 11, 2026 [Yahoo! Finance]
Low
Report
Medincell to Participate in Leerink and Jefferies Miami Investor Conferences, March 8 – 11, 2026 [Yahoo! Finance]
3/4
08:44 am
teva
Teva Pharmaceutical Industries (TEVA) had its "overweight" rating reaffirmed by Piper Sandler. They now have a $41.00 price target on the stock, up from $40.00.
Low
Report
Teva Pharmaceutical Industries (TEVA) had its "overweight" rating reaffirmed by Piper Sandler. They now have a $41.00 price target on the stock, up from $40.00.
3/3
10:11 pm
teva
????????:???????????????????2035????354.1??????? [CNET News]
Low
Report
????????:???????????????????2035????354.1??????? [CNET News]
3/3
05:26 pm
teva
Teva and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advance duvakitug [Yahoo! Finance]
Low
Report
Teva and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advance duvakitug [Yahoo! Finance]
3/3
05:00 pm
teva
Teva and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advance duvakitug
Low
Report
Teva and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advance duvakitug
3/2
03:32 pm
teva
The Best Healthcare Stock to Invest $1,000 in Right Now [Yahoo! Finance]
Low
Report
The Best Healthcare Stock to Invest $1,000 in Right Now [Yahoo! Finance]
3/1
03:26 pm
teva
How Positive Duvakitug IBD Data and New Schizophrenia Drug Filing Will Impact Teva (TEVA) Investors [Yahoo! Finance]
Low
Report
How Positive Duvakitug IBD Data and New Schizophrenia Drug Filing Will Impact Teva (TEVA) Investors [Yahoo! Finance]
2/28
02:14 pm
teva
SNL’s Will Forte On How Huntington’s Disease Has Become A Family Issue [Forbes]
Low
Report
SNL’s Will Forte On How Huntington’s Disease Has Become A Family Issue [Forbes]
2/27
07:03 pm
teva
Teva And Sanofi Data Add Potential Branded Growth Option In IBD [Yahoo! Finance]
Low
Report
Teva And Sanofi Data Add Potential Branded Growth Option In IBD [Yahoo! Finance]